Filing Flows › Transact Technologies (TACT) › R&D spending
Transact Technologies (TACT) R&D spending by quarter
Transact Technologies' R&D spending was $1.2M in Q2 2026 (second quarter 2026), -11% from Q1 2026. Over the last 7 quarters it ranged from $1.2M (Q2 2026) to $1.7M (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.2M | -11% | -29% |
| Q1 2026 | $1.4M | -18% | -16% |
| Q4 2025 | $1.7M | +2% | +7% |
| Q3 2025 | $1.7M | -4% | — |
| Q2 2025 | $1.7M | +6% | — |
| Q1 2025 | $1.6M | +4% | — |
| Q4 2024 | $1.6M | — | — |
Q2 2026 at a glance
Transact Technologies, Q2 2026: revenue $13.9M (+1% year over year), operating margin -0.4%, net loss $50K, operating cash flow $2.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Transact Technologies' R&D spending?
Transact Technologies' R&D spending was $1.2M in Q2 2026 (second quarter 2026), -11% from Q1 2026.
How has Transact Technologies' R&D spending changed?
Over the last 7 quarters it ranged from $1.2M (Q2 2026) to $1.7M (Q2 2025).